Certain drug classes contain caustic ingredients that damage the soft, delicate lining of the esophagus. More specifically, they cause "inflammation or an erosion of the esophageal lining, resulting ...

Eosinophilic esophagitis (EoE) is an allergic inflammatory disorder that affects the esophagus, causing distressing symptoms such as difficulty swallowing in adolescents and adults, and vomiting ...

Serum chromogranin A (CgA) levels increase secondary to drug-induced decreases in gastric ... Patients with acute endoscopically proven reflux esophagitis with at least 1 of 3 symptoms typical ...

“The EsoCap novel smart drug delivery technology will enable targeted and long-lasting local therapy of the esophagus for the first time,” said Isabelle Racamier, EsoCap CEO. “We carried out ...

Do not administer concomitantly with any other medications through same IV site and/or tubing. GERD with erosive esophagitis: Adults: Give by IV inj (no less than 3 mins) or IV infusion (10–30 ...

Fangyu Zhang, 34, engineered single-cell, self-propelled microalgae into a swarm of swimming biorobots that can be used to ...

CALY-002 is under development for the treatment of eosinophilic esophagitis, celiac disease and unspecified dermatological disorders. It is a fully-humanized monoclonal antibody also administered ...

Lupin has entered into a patent license agreement with Takeda to commercialise Vonoprazan tablets, a novel gastrointestinal ...

Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialize Vonoprazan tablets ...

Lupin share price traded under selling pressure in Wednesday's trade to quote at Rs 2,230.60 per share on the NSE, down 1.75 ...

Nucala is the only other drug approved in the indication ... its label to chronic obstructive pulmonary disorder (COPD), ...

The company, which has more than 200 employees in Philadelphia, expects to raise a minimum of $850 million when the sale ...